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The feasibility of ultra thin-layer chromatography atmospheric pressure matrix-assisted laser
desorption ionization mass spectrometry (UTLC-AP-MALDI-MS) has been studied in the
analysis of small molecules. Because of a thinner adsorbent layer, the monolithic UTLC plates
provide 10–100 times better sensitivity in MALDI analysis than conventional high perfor-
mance thin-layer chromatography (HPTLC) plates. The limits of detection down to a low
picomole range are demonstrated by UTLC-AP-MALDI-MS. Other advantages of UTLC over
HPTLC include faster separations and lower solvent consumption. The performances of
AP-MALDI-MS and vacuum MALDI-MS have been compared in the analysis of small drug
molecules directly from the UTLC plates. The desorption from the irregular surface of UTLC
plates with an external AP-MALDI ion source combined with an ion trap instrument provides
clearly less variation in measurements of m/z values when compared with a vacuum
MALDI-time-of-flight (TOF) instrument. The performance of the UTLC-AP-MALDI-MS
method has been applied successfully to the purity analysis of synthesis products produced by
solid-phase parallel synthesis method. (J Am Soc Mass Spectrom 2005, 16, 906–915) © 2005
American Society for Mass SpectrometryIn recent years, improvements in thin-layer chroma-tography (TLC) instrumentation and methods aswell as the introduction of the high-performance
thin-layer chromatography (HPTLC) has increased the
use of this simple, inexpensive, and efficient method.
TLC allows simultaneous analysis of many samples on
one plate, the plates are disposable, and therefore
memory effects can be avoided, solvent consumption is
low, and a number of nondestructive detection methods
with appropriate derivatization reagents can be used in
sequence. The modern HPTLC technique, combined
with automated sample application and densitometric
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doi:10.1016/j.jasms.2005.02.025scanning, has proven to be sensitive, reliable, and
suitable for the qualitative and quantitative analysis of
pharmaceutical, environmental, toxicological, forensic,
and food samples [1–9].
The development of miniaturized ultra-thin-layer
chromatography (UTLC) [10] in addition to the devel-
opment of other miniaturized analytical methods [11] is
currently a hot topic in analytical chemistry. The UTLC
method combined with UV or diode-array detection
(DAD) provides faster elution times (1–6 min), lower
solvent consumption (1–4 ml), and lower detection
limits than those obtained when using the conventional
TLC or HPTLC methods [12]. However, the weakness
of UTLC when compared with HPTLC is reduced
resolution caused by shorter elution distances and a
smaller overall specific adsorption surface area [12].Several methods, such as ultraviolet/visible (UV/
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Fourier transform infrared (FTIR), and Raman spec-
troscopy have been applied for the in situ detection of
analyte zones on a TLC plate [12–15], the most
common of these being UV and fluorescence. In
qualitative TLC, the identification of the compounds
is based on either the color reactions of the separated
sample zones or on the comparison of the RF values of
the analyte and a standard compound after visualiza-
tion under a UV lamp. Quantitative TLC measure-
ments are performed by densitometric scanning us-
ing either one or several wavelengths in absorbance
or fluorescence mode. With densitometric measure-
ments the analytes are identified by their corrected RF
values and by using UV/VIS-spectra of the analytes
and standard compounds measured in situ. In those
cases in which the standard compounds are not
available (e.g., the screening of new natural agents or
combinatorial chemistry samples), the identification
of unknowns has to be performed using a specific
technique, such as mass spectrometric detection.
The combination of TLC andMS has been a very active
research area over the last few years [5–21]. TLC-MS has
most frequently been performed as an off-line process in
which the sample is scraped and extracted from the plate
before MS analysis [5, 22, 23], or is analyzed as such with
the use of various in situ techniques [15, 16, 19 –21, 24 –31],
the most common of these being TLC-liquid secondary
ion mass spectrometry (LSIMS), TLC-fast atom bombard-
ment (FAB), TLC-matrix-assisted laser desorption/ioniza-
tion (MALDI), and TLC-surface-assisted desorption/ion-
ization (SALDI).
MALDI, as a simple and fast technique, has been
found to be the most promising method for direct
TLC-MS analysis [15, 16, 19, 24 –29]. The operational
parameters of TLC-MALDI-MS have been well charac-
terized. For example, it has been observed that a lower
analyte to matrix ratio for lowmass molecules is needed
compared to MALDI analysis of high mass molecules
[26]. Different approaches on how to add the matrix
have also been investigated, electrospraying the matrix
on top of the separated analyte zones being one of the
most promising techniques [26 –29]. The use of different
matrix compounds has also been compared [19, 20,
24 –29]. Many of the matrices used in TLC-MALDI-MS
cause interfering mass peaks at low mass numbers.
However, it has been shown that the matrix back-
ground can be suppressed by using appropriate
analyte-to-matrix molar ratio in MALDI measurements
[23, 26, 32–35]. New potential matrices, producing low
matrix background, have also been introduced [16, 20,
21, 27, 30, 31]. A disadvantage of the MALDI method
has been the relatively poor repeatability in quantitative
analysis. However, a recent study demonstrated good
precision with an internal standard method [29] in
which the internal standard was predeveloped over the
plate. Furthermore, working with vacuum MALDI
sources, as was done in all the TLC-MALDI papers
published to date, makes the method somewhat riskysince large amounts of chromatographic material are
directly introduced inside the vacuum chamber of a
mass spectrometer. This can be avoided by working
with the recently introduced atmospheric pressure
MALDI (AP-MALDI) [32, 36 –38] source. Changing the
sample plates is faster with AP-MALDI instruments
than with vacuum MALDI instruments since pump
down is not needed. Additionally, the ionization pro-
cess in AP-MALDI compared with vacuum MALDI has
been reported to be softer and therefore can produce
more intact protonated molecule and less fragmentation
than in vacuum MALDI [32].
In this study, we present a novel UTLC-AP-
MALDI-MS method which was tentatively introduced
for the first time in our earlier work [39]. UTLC and
HPTLC methods using both the UV and AP-
MALDI-MS detection, and UTLC combined with AP-
and vacuum MALDI-MS, are compared in the analysis
of small molecules. Commercial, pharmaceutically in-
teresting compounds as well as heterocyclic 1,2,3-
triazoles produced by solid-phase combinatorial chem-
istry are used in the comparison.
Experimental
Reagents
In the experiments, two types of compound were used
(Figure 1). The reference standards of midazolam, ve-
rapamil (as hydrochloride salt) and metoprolol (as
tartrate salt) were obtained from Roche (Basel Switzer-
land), Sigma-Aldrich (Steinheim, Germany), and ICN
Biomedicals (Aurora, OH), respectively. Five other
compounds, which all are 1,2,3-triazoles (Figure 1),
were selected from a combinatorial library synthesized
in our laboratory by the solid-phase method described
by Harju et al. [40]. -Cyano-4-hydroxycinnamic acid
(-CHCA), used as a matrix compound for MALDI-MS
analysis, was purchased from Fluka Chemie (Buchs,
Switzerland). All organic solvents were of analytical or
chromatographic grade. Ethyl acetate was purchased
from Merck (Darmstadt, Germany), acetonitrile and
dichloromethane from Rathburn (Walkerburn, Scot-
land), and n-hexane and methanol from J. T. Baker
(Deventer, Holland). Trifluoroacetic acid, acetic acid,
and 25% ammonia solution were from Acros Organics
(Geel, Belgium), Rathburn (Walkerburn, Scotland), and
Riedel-de Haën (Seelze, Germany), respectively.
Sample and Matrix Solutions
All stock solutions of compounds were prepared by
dissolving a compound into a concentration of 1 mg/
ml, triazole 1 and 2 with dichloromethane/methanol
(50:50 vol/vol), triazole 3 and 4, and metoprolol with
methanol, and midazolam and verapamil with acetoni-
trile. The working solutions of the compounds were
prepared by diluting a stock solution with the same
solvent used to prepare the stock solution. The stock
the compounds used.
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the following method: 20 mg of -CHCA was diluted
with 2 parts of acetonitrile and 1 part of methanol
containing 0.1% trifluoroacetic acid. The working solu-
tions of the matrix were prepared by diluting the stock
solution with acetonitrile.
UTLC and HPTLC Method
For planar chromatography, silica gel 60 F254 HPTLC
plates (glass support) of 10  10 cm (Merck) and
monolithic UTLC plates (glass support) of 3.6  6 cm
(Merck) were used. The plates were prewashed once
with acetonitrile before sample application. Sample
solutions were sprayed as a thin rectangular band onto
the adsorbent in amounts of 1 or 10 l with a Linomat
IV (Camag, Muttenz, Switzerland) at a flow rate of
4l/min as 3-mm-long bands with 4 mm spaces. The
total amount of samples on the plate was between 1
pmol and 10 nmol.
The mobile phase composition was optimized with
the help of the PRISMA model [41– 45]. Ethyl acetate-
n-hexane (1:2 vol/vol) containing 2% acetic acid was
used as the final mobile phase for triazoles, and ethyl
acetate containing 0.5% ammonium hydroxide for
drugs. The plates were eluted in a saturated chamber to
the distance of 2 cm for UTLC and 5 cm for HPTLC. The
elution time was 2–4 min for UTLC and 5–8 min for
HPTLC. After elution, HPTLC plates were first detected
visually under a UV lamp (Desaga, Heidelberg, Ger-
many) and finally with a Camag TLC Scanner II (Mut-
tenz, Switzerland) controlled by the CATS 3.17 program
at   222 nm for drugs and 228 nm for triazoles (D2
lamp). The UTLC plates could only be detected using a
TLC Scanner II owing to the lack of a fluorescent
indicator. The densitometric measurements were per-
formed in absorption and reflection modes. In situ UV
spectra of the compounds were measured at wave-
length range of 190–450 nm.
MALDI Instrumentation
The AP-MALDI mass spectrometry system consisted of
an AP-MALDI ion source (Agilent Technologies, Ger-
many) combined with an Esquire 3000plus ion trap
instrument (Bruker Daltonics, Bremen, Germany). The
AP-MALDI interface has been described in detail earlier
by Doroshenko et al. [32]. After adding of the matrix,
UTLC and HPTLC plates were attached to the face of an
in-house-modified AP-MALDI target plate with
double-sided conductive tape after cutting the plate to
match the target plate. A nitrogen laser at 337 nm (10
Hz) was focused on the sample zone on a plate, the size
of the laser spot being 0.5 mm [32]. The laser pulse
energy was adjusted with an attenuator to 8.5 (arbitrary
unit) providing an estimated pulse energy 264 J from
the laser. The ions formed in the laser pulses were
directed to the ion trap via extended capillary of the ionFigure 1. Structures and molecular weights (average masses) of trap instrument. A potential of 2200 V was applied to
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flow rate of 6 L/min and a temperature of 150 °C. The
ion trap parameters were as follows: the accumulation
time, 200 ms, the “averages” were set at 10, and the
“rolling averaging” was “off.” The voltages of the
skimmer and capillary exit were 34 and 160 V, respec-
tively. The mass spectra were recorded in the range of
m/z 100–500. For MS/MS measurements, the cut-off
value was set to m/z 100 and the fragmentation ampli-
tude to 2.0. Other parameters were the same as in the
MS mode. The instrument was calibrated using external
calibration method and calibration mixtures provided
by the instrument manufacturer. The resolution was
calculated to be about 950 within the measured mass
range.
Vacuum MALDI measurements were performed us-
ing a Bruker Autoflex MALDI-time-of-flight (TOF) in-
strument (Bruker Daltonics) operating with a nitrogen
laser at 337 nm (5 Hz). The size of the laser spot was
approximately 100–150 m (private communication,
Bruker Daltonics). After adding of the matrix, UTLC
plates were attached to the face of an in-house-modified
MALDI target plate with double-sided conductive tape
after cutting the plate to match the target plate. MS
instrument was operated in positive ion mode with the
applied acceleration voltage of 20 kV. Attenuation value
related to laser power in one pulse were 47% for drugs
and 50% for triazoles. Averages of 50 pulses were
recorded for MS spectra. The calibration was done by
Table 1. RF values and plate heights (H) of the compounds
studied by the UTLC and HPTLC methods with UV-
densitometry
Comp. Name
RF H (m)
UTLC HPTLC UTLC HPTLC
1 Triazole 1 0.19 0.11 328 125
2 Triazole 2 0.10 0.03 184 445
3 Triazole 3 0.80 0.54 87 35
4 Triazole 4 0.50 0.22 102 96
6 Midazolam 0.88 0.22 68 115
7 Verapamil 0.97 0.24 41 90
8 Metoprolol 0.37 0.04 314 296
Table 2. Repeatability of UTLC-UV and UTLC-AP-MALDI-MS
standard deviation (RSD %). Sample amount on plate was 0.1 nm
Compound
UV
RF Peak area
Triazole 1
Mean  SD 0.29  0.005 185.3  15
RSD % 1.7 8.3
Midazolam
Mean  SD 0.53  0.01 480.0  29
RSD % 1.9 6.0
Metoprolol
Mean  SD 0.16  0.005 110.4  6.
RSD % 3.1 6.2using [MH] (m/z 190) and [M Na] (m/z 212) ions
of the matrix as internal calibration points. The resolu-
tion was calculated to be about 1200 within the mea-
sured mass range.
Results and Discussion
Mobile Phase and UV-Detection
The preoptimization of the mobile phase with UTLC
plates was carried out with the help of PRISMA
model [41– 45] using UV densitometric detection. The
optimal solvent composition for triazoles (Com-
pounds 1–5) was ethyl acetate-n-hexane (1:2) contain-
ing 2% acetic acid, and for the drug substances
(Compounds 6 – 8) ethyl acetate containing 0.5% am-
monium hydroxide. With these eluents, the RF values
of the compounds studied were between 0.1 and 0.97
with UTLC and between 0.03 and 0.54 with HPTLC
plates, (Table 1) providing good separation effi-
ciency. The RF values obtained by UTLC are higher
because the total surface area is smaller, i.e., the
adsorbent layer is thinner and the specific surface
area is smaller in UTLC (10 m and about 350 m2/g)
than in HPTLC plates (0.2 mm and about 500 m2/g)
[12]. Furthermore, the plate heights (H) were in most
of the cases higher with UTLC plates than with
HPTLC plates (Table 1). The elution time was about
two times shorter with UTLC (2–4 min) than with
HPTLC (5–8 min) and the solvent consumption in the
elution of one UTLC plate was 3 ml, which was about
three times less than with HPTLC. All these UTLC
results are parallel to the results reported earlier by
Hauck and Schulz [12].
The relative standard deviations (RSD) of the RF
values were between 1.7 and 3.1% (Table 2) indicating
good repeatability of the separation with UTLC. The
quantitative repeatability of the UTLC-UV measured
as peak heights or areas were acceptable, RSDs being
below 9% (Table 2). The limits of detection (LODs)
measured using a UV densitometer (S/N  3) were
about 1–10 times lower with UTLC than HPTLC for
most of the compounds studied (Table 3). Although
ods (n  5) as mean, standard deviation (SD), and relative
d matrix amount was 10 nmol
AP-MALDI-MS
Peak height Abs. abund. of [M  H]
11.7  0.4 540  136
3.8 25.1
22.6  0.8 1830  399
3.7 21.8
7.4  0.4 975  216meth
ol an
.3
.2
9
5.7 22.1
31
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method, the specificity of the method is not good
enough for detailed structural characterization of the
compounds. Therefore, the capability of AP-
MALDI-MS for the identification of compounds di-
rectly from UTLC and HPTLC plates was studied.
UTLC/HPTLC-MALDI-MS
For MALDI-MS analysis, the use of a matrix was
required since the ionization efficiency of the com-
pounds studied from the UTLC and HPTLC without
the matrix was very poor. -Cyano-4-hydroxycinnamic
acid (-CHCA) was selected to be as a matrix com-
pound, since it provided good ionization efficiency for
the compounds studied. The matrix was sprayed over
the sample zone with a TLC applicator device (Linomat
IV), by which the matrix could be deposited precisely in
the center of the sample zone in the form of narrow
bands. The spreading of the sample zone was not
visually observable. The application time for the matrix
onto one sample zone of the UTLC plate was only 15 s
(1 l applied with a flow rate of 4 l/min) providing a
very rapid preparation of the UTLC plates for
MALDI-MS analysis. In conclusion, the Linomat
spray-on technique provides the same advantages ob-
tained by using the electrospraying technique reported
by Mowthorpe et al. [26].
The matrix amount in MALDI-MS and TLC-
MALDI-MS has been shown to have a significant effect
Table 3. Limits of detection (LODs) of UTLC/HPTLC-UV and U
Compound
UV non-eluted
(pmol)
UV eluted
(pmol)
AP-M
non
(p
Triazole 1
UTLC 38 69
HPTLC 23 79
Triazole 2
UTLC 88 154
HPTLC 25 75
Triazole 3
UTLC 33 84
HPTLC 68 539
Triazole 4
UTLC 42 79
HPTLC 266 819 6
Midazolam
UTLC 1 25
HPTLC 4 326
Verapamil
UTLC 7 66
HPTLC 9 622
Metoprolol
UTLC 49 54
HPTLC 25 345on the sensitivity, repeatability, and matrix background[23, 26, 33–35, 46, 47]. The effect of the matrix amount
on sensitivity and selectivity was studied by applying 1
nmol of midazolam and triazole 1 onto the UTLC and
HPTLC plates. The concentration of the -CHCA solu-
tion was varied in the optimization experiments be-
tween 190 ng/l and 13.3 g/l, thus the total amount
of -CHCA on the plate varied between 1–1000 nmol.
The optimal matrix amount was 10 nmol for UTLC
(about 2.66 nmol/mm2) and 100 nmol for HPTLC
(about 22.2 nmol/mm2). The lower amount of matrix
reduced sensitivity and the higher amount caused in-
creased matrix background and therefore decreased
selectivity.
The effect of the dry gas (N2) temperature on the
ionization with AP-MALDI-MS was tested because it
has been reported that the temperature affects the
analyte-matrix dissociation process in AP-MALDI-
MS, i.e., at low temperatures, formation of the ana-
lyte/matrix clusters/dimers has been observed,
whereas high temperature can cause fragmentation of
molecular ion of the analytes [32]. The tests were
made between 100–250 °C using 1 nmol of triazole 1
on the UTLC plate. The absolute abundance of the
protonated molecule doubled when the temperature
was raised from 100 to 150 °C. The rise in tempera-
ture from 150 to 250 °C increased fragmentation and
reduced the abundance of the protonated molecule.
The temperature of dry gas had no clear effect on the
specificity since no additional peaks appeared, and
the ratio of the relative abundances of the matrix ions
/HPTLC-AP- and vacuum MALDI-MS (S/N  3)
Method
-MS
ed AP-MALDI-MS
eluted (pmol)
Vacuum
MALDI-MS
non-eluted
(pmol)
Vacuum
MALDI-MS
eluted
(pmol)
12.5 10 33
500 —
100 90
2140 —
300 16
750 —
400 90
10000 —
4.8 4 5
300 —
1.3 3
300 —
6.4 4
600 —TLC
ALDI
-elut
mol)
4
280
85
750
30
500
100
700
0.5
30
0.5
22
4and the analyte ions did not change significantly
911J Am Soc Mass Spectrom 2005, 16, 906–915 UTLC-AP-MALDIwhen the temperature was raised from 100 to 250 °C.
The optimal temperature was 150 °C, which was
selected for the further studies.
The target plate of the AP-MALDI system used in
this study was maintained in a fixed position mode.
With this mode the matrix disturbances were strong
during the first laser pulses, but the relative abundances
of the analyte ions compared with the matrix ions
increased along with the number of pulses. The same
observation was made with vacuum MALDI-MS. This
suggests that the analyte molecules were not diffused
thoroughly into the matrix and the concentration of the
analytes was higher on the surface of the UTLC plate
than on the surface of the matrix. When using the UTLC
Figure 2. Replicate measurements of (a) triazole 1 [M  Na]
ions (m/z  252.111) by UTLC-vacuum MALDI-MS (internal
calibration mode); n  27, and (b) triazole 1 [M  H] ions (m/z 
230.129) by UTLC-AP-MALDI-MS (external calibration mode); n
 23. (filled square)  measured mass, (line)  calculated mass.
Table 4. Main analyte ions in mass spectra measured by UTLC-
was 1 nmol and matrix amount 10 nmol
UTLC-AP-MALDI-MS
Comp. [M  H]
m/z (rel. abund)
[M  Na] Other ions
Triazole 1 230 (100) 252 (25) 124a (36) T
Triazole 2 236 (100) 258 (79) 130c (84) T
Triazole 3 146 (100) T
Triazole 4 186 (50) 208 (100) T
Midazolam 326 (100) — — M
Verapamil 455 (100) — 303 (12) V
Metoprolol 268 (100) 290 (15) Mam/z 124  [C6N3H10]
, b107  [CH2C6H4OH]
, c130  [C4N3O2H8]
plate with a matrix amount of 10 nmol, the signal lasted
for about 30 s in the fixed mode. By increasing the
matrix amount, the signal lasted longer and, for exam-
ple, with 100 nmol the analyte ions were observed for a
few min. The long-lasting signal allows sequential mass
analysis including, for example, optimization of opera-
tion parameters, measurements of MS, and different
kinds of MS/MS spectra in positive and negative ion
mode from sample zone.
Figure 2 shows the variation of m/z values for
triazole 1 measured from different sample zones on
the UTLC plates by vacuum MALDI-TOF-MS (Figure
2a) using internal calibration, and by AP-MALDI-ion
trap-MS (Figure 2b) using external calibration. Vari-
ation in m/z values was clearly less with AP-MALDI-
ion trap-MS (0.08 u) than with vacuum MALDI-
TOF-MS (0.32 u). These results are in accordance to
the earlier studies in which it has been shown that
irregular surface materials, such as polymer mem-
branes and TLC plates, can lead to decreased mass
accuracy by vacuum MALDI-TOF-MS [48, 49]. How-
ever, AP-MALDI-ion trap-MS provides the coupling
of UTLC without compromising in mass accuracy,
taking into account that the used ion trap is not a high
resolution instrument. Parallel results have been ob-
tained by TLC-MALDI-Fourier transform (FT) MS
using an external ion source [50].
Spectra
The AP- and vacuum MALDI mass spectra of the
compounds studied were measured by applying 1 mol
of the analyte and 10 nmol of the matrix on the UTLC
plate (Table 4). The measured mass spectra produced
by both sources exhibited an abundant protonated
molecule and only the compounds including the hy-
droxy group (triazole 1 and 2, and metoprolol) pro-
duced an abundant sodium adduct ion. The spectra of
triazoles 1 and 2 and verapamil also showed some
fragment ions. The appearance of [M  Na] in addi-
tion to formation of the fragment ions was somewhat
stronger with vacuum MALDI-MS than with AP-
and UTLC vacuum MALDI-MS before elution. Sample amount
UTLC-Vacuum-MALDI-MS
mp. [M  H]
m/z (rel. abund)
[M  Na] Other ions
ole 1 230 (48) 252 (100) 124a (83), 107b (10)
ole 2 236 (-) 258 (100) 130c (30), 107b (20)
ole 3 146 (100)
ole 4 186 (50) 208 (100)
zolam 326 (100) — —
amil 455 (100) — 303 (63)
prolol 268 (100) 290 (8)AP-
Co
riaz
riaz
riaz
riaz
ida
erap
eto
or an
912 SALO ET AL. J Am Soc Mass Spectrom 2005, 16, 906–915MALDI-MS, which indicates a more energetic ioniza-
tion process of vacuum MALDI-MS under operational
conditions used in this study since [M  Na] ions are
often more stable than [M  H]. Also, the stabilization
of the protonated molecule by collisional cooling was
more efficient in AP-MALDI-MS than in vacuum
MALDI-MS.
Figure 3 illustrates as an example the AP- and
vacuum MALDI mass spectra of triazole 1 and mida-
zolam (1 nmol) measured from the eluted UTLC plate
and AP-MALDI mass spectrum of triazole 1 (1 nmol)
from the eluted HPTLC plate. In vacuum MALDI-MS,
the abundant matrix background ions (marked as an
asterisk) were observed below m/z 250. AP-MALDI
Figure 3. Mass spectra of triazole 1 (a–c) and
MALDI-MS (a) and (d), UTLC-AP-MALDI-MS
amounts are 1 nmol and matrix (-CHCA) amou
main matrix ions are marked with an asterisk. Fmass spectra showed the same matrix ions at a massrange below m/z 250 but also matrix dimers, which
were not observed with vacuum MALDI-MS. The
dimers are rapidly stabilized by collisional cooling in
AP-MALDI-MS and they can be transferred into the
ion trap. The collisional cooling in vacuum
MALDI-MS is significantly less than in AP-
MALDI-MS leading to dissociation of the dimers in
the vacuum MALDI-TOF experiments. However, all
the analyte ions were visible using both methods. The
matrix background is significantly lower with mida-
zolam (Figure 3e) than with triazole 1 (Figure 3b).
This might be because the physical and chemical
properties, such as proton affinity, hydrophobicity,
absorbtivity at 337 nm of midazolam, are more favor-
zolam (d) and (e) measured by UTLC-vacuum
d (e), and HPTLC-AP-MALDI-MS (c). Sample
as 10 nmol (UTLC) and 100 nmol (HPTLC). The
alyte fragment ions (F), see Table 4.mida
(b) an
nt wable for efficient ionization than those of triazole 1.
913J Am Soc Mass Spectrom 2005, 16, 906–915 UTLC-AP-MALDIOn the other hand, the extraction efficiency from the
inner parts of the silica layer to the matrix during the
addition of the matrix solution might be better with
midazolam than with triazole 1. The comparison
between UTLC- (Figure 3b) and HPTLC-AP-
MALDI-MS (Figure 3c) spectra of triazole 1 indicates
that the matrix disturbances are less with the UTLC
than with the HPTLC plate. This is because the
optimal matrix amount with UTLC plates (10 nmol) is
ten times less than with HPTLC plates (100 nmol).
Limit of Detection and Repeatability
The limits of detection (LODs) (Table 3) with UTLC-AP-
MALDI-MS (S/N  3) after elution were 10–400 pmol
for triazoles (1–4), and 1–7 pmol for the drug substances
(6–8). The LODs with HPTLC-AP-MALDI-MS were
500–10,000 pmol for triazoles (1–4) and 300–600 pmol
for drug substances (6–8). These results show that with
AP-MALDI-MS UTLC plates provide about 10–100
times better sensitivity than HPTLC plates. This holds
also when the measurements were performed from the
application zone (i.e., before elution). The better sensi-
tivity with UTLC plates can be attributed to a thinner
adsorbent layer of the UTLC plates. It follows that the
number of molecules per surface area is significantly
higher on the UTLC plate than on the HPTLC plate.
Furthermore, with UTLC plates the analyte molecules
are extracted from the inner parts of the adsorbent onto
the surface more efficiently than with HPTLC. The laser
pulse is capable of ionizing the compounds efficiently
only from the surface of the adsorbent. The spreading of
the zone during the elution reduced sensitivity, as the
LODs measured from the application zone were about
2–10 times lower than those measured after elution.
This suggests that the sample application with a nar-
rower band might lead to lower LODs especially with
the UTLC method. The LODs obtained with AP-
MALDI-MS and vacuum MALDI-MS were mostly at
the same level.
Quantitative repeatability of the UTLC-AP-MALDI-MS
was studied on five different plates after elution by using 0.1
nmol of triazole 1, midazolam, andmetoprolol, and 10 nmol
of the matrix. The relative standard deviations were about
22–25% (Table 2) showing that the method is likely to be
more suitable for semi-quantitative than for analysis in
which high quantitative accuracy is required. Nevertheless,
accurate quantitative results can be obtained using UV den-
sitometry.
4™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™
Figure 4. The identification of synthesis product (triazole 5) and
by-product in crude product. (a) UTLC-UV densitogram of a synthe-
sis sample and (b–e) AP-MALDI-MS spectra of the separated com-
pounds; (b) MS spectrum of Compound A (by-product), (c) MS/MS
spectrum of ion m/z 369 of Compound A, (d) MS spectrum of
Compound B (m/z 176, m/z 198, and m/z 107 are [M  H], [M 
Na], and fragment ion [CH C H OH] of the synthesis product,2 6 4
respectively, (e) MS/MS spectrum of ion m/z 176 of Compound B.
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The UTLC-AP-MALDI-MS method was applied to the
identification of the synthesis product (triazole 5, mw
175.2) and possible by-products in a crude product. The
compounds were separated using ethyl acetate-n-
hexane 1:2 containing 2% acetic acid as an eluent
(Figure 4). The UV densitogram clearly shows two
peaks with RF values of 0.10 (A) and 0.46 (B) in Figure
4a. The AP-MALDI-MS spectrum of synthesis product
(Peak B, Figure 4d) reveals an abundant protonated
molecule of triazole 5 (m/z 176), which produces in
MS/MS analysis (Figure 4e) a product ion
[CH2C6H4OH]
 (m/z 107) confirming that the product is
triazole 5. The ion m/z 107 is a common fragment ion for
triazoles containing the phenolic functionality. The MS
spectrum of by-product (Peak A, Figure 4b) shows an
extraordinary ion at m/z 369, which does not exist in the
spectrum of the matrix. The product ion spectrum of ion
m/z 369 (Figure 4c) showed an ion at m/z 107 which is
also recognized in the product ion spectrum of triazole
5. This suggests that Peak A represents a synthesis
by-product. After identification of the synthesis product
with AP-MALDI-MS, the purity percentage of triazole 5
was calculated to be 80% in a crude product based on
UV densitometry measurement.
Conclusions
We have reported herein the feasibility of a novel
UTLC-AP-MALDI-MS method for the analysis of small
drug molecules. The UTLC method has been compared
with the HPTLC method with UV and AP-MALDI-MS
detection and UTLC-AP-MALDI-MS has been com-
pared with UTLC-vacuum MALDI-MS. The UTLC-AP-
MALDI-MS analysis of crude synthesis sample pro-
duced by combinatorial chemistry has also been
applied. The advantages of UTLC over HPTLC include
faster separations and reduced solvent consumption.
The use of MS provides enhanced specificity over UV
detection and UTLC-AP-MALDI-MS significantly im-
proved sensitivity when compared with HPTLC-AP-
MALDI-MS. The applicability of UTLC-AP-MALDI-MS
has been shown to be good enough for the identification
of small drug molecules in relatively simple samples in
MS mode. In more complex samples, the use of MS/MS
is necessary. In conclusion, UTLC-AP-MALDI-MS pro-
vides improvements to the present (HP)TLC-vacuum
MALDI-MS methods, preserving at the same time
many of the advantages of the TLC, such as fast and
parallel analysis, a disposable stationary phase that
avoids memory effects, and the possibility to use other
analytical techniques before MALDI-MS analysis.
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